INTRODUCTION
FGFs play essential roles in numerous biological processes during vertebrate development. Studies performed with dominant-negative FGF receptors provided clear support for There are at least 14 members of the fibroblast growth an essential role of FGFs during amphibian development factor (FGF) 2 family and at least 4 FGF-receptor genes (re- (Amaya et al., 1993) . In humans, defects in three of the FGFviewed in Miller and Rizzino, 1994 ; also see Smallwood et receptor genes have been linked directly to genetic disorders al., Yamasaki et al., 1996) . It is now clear that of bone development (Shiang et al., 1994; Rousseau et al., 1994; Reardon et al., 1994; Muenke et al., 1994) , and gene targeting studies provide unequivocal proof for the require-1 To whom correspondence should be addressed. Fax: 402-559-ment of specific FGF receptors during mouse development
4651. E-mail: ARIZZINO@UNMC.EDU. (Deng et al., 1994 (Deng et al., , 1996 Yamaguchi et al., 1994 ; Colvin et 2 Abbreviations used: ES, embryonic stem; EC, embryonal carcial., 1996) . In addition, gene targeting studies have identified noma; FGF, fibroblast growth factor; ICM, inner cell mass; FBS, the requirement for several FGFs during mouse developfetal bovine serum; LIF, leukemia inhibitory factor; RA, retinoic acid; tPA, tissue plasminogen activator; Endo B, keratin 18.
ment. Inactivation of both alleles of the FGF-3 gene causes defects in the development of the inner ear and the tail and 1985; Rizzino et al., 1988; Miller and Rizzino, 1996b) . However, EC cells and ES cells may produce all the FGF-4 that these mice often fail to survive to adulthood (Mansour et al., 1993) . Gene targeting studies have also directly implicated they require. Thus, it is unclear whether FGF-4 is an essential autocrine growth factor for early embryonic cells. In this FGF-5 and FGF-7 in hair growth and development (Hé bert et al., 1994; Guo et al., 1996) . Thus far, the most severe report, we have addressed this important issue and several related questions by employing gene targeting to inactivate effects have been observed with the inactivation of the FGF-4 gene (Feldman et al., 1995) .
both alleles of the FGF-4 gene in ES cells. Specifically, the work described in this report addressed four questions: (1) FGF-4 appears to be the first FGF expressed during mammalian development. Its expression has been observed at Can FGF-4 0/0 ES cells be isolated in culture; (2) do FGF-4 0/0 ES cells require or respond to FGF-4 in vitro; (3) can the RNA level as early as the four-cell stage (Rappolee et al., 1990) . By the blastocyst stage, FGF-4 RNA expression FGF-4 0/0 ES cells differentiate in culture and do the differentiated cells respond to FGF-4; (4) can FGF-4 0/0 ES cells form is restricted to the cells of the inner cell mass (ICM) (Niswander and Martin, 1992) , which give rise to the three emtumors in vivo and is the range of cell types in these tumors different from the tumors derived from their unmodified bryonic germ layers. As the embryo undergoes gastrulation, FGF-4 RNA is restricted to the primitive streak where it counterparts? continues to be expressed for several additional days. After organogenesis is initiated, FGF-4 is expressed in many tissues, including the myotome cells of mature somites, the
MATERIALS AND METHODS
branchial arches, and the apical ectodermal ridge of the developing limb. These findings prompted speculation that
Growth and Differentiation of ES Cells
FGF-4 plays important roles at multiple stages of develop-R1 ES cells (Nagy et al., 1993) were provided by A. Nagy and J. ment (Niswander and Martin, 1992) . This was confirmed Rossant (Mount Sinai Hospital, Toronto, Canada) and D3 ES cells for early development by the finding that mouse embryos (Doetschman et al., 1985) were provided by T. Doetschman when FGF-4 0/0 embryos are cultured in vitro, the ICM and 2 ng/ml recombinant human leukemia inhibitory factor (LIF; Pepro Tech Inc., Rocky Hills, NJ) as described previously (Ma et al., 1992 receptors at the RNA and protein levels  4 allele contained a 7.8-kb fragment of the FGF-4 gene (XhoI-SalI), Mummery et al., 1993) , and, at least for F9 EC cells, FGFderived from a 16-kb genomic clone (BamHI-BamHI). The MluI 4 appears to be the primary, if not the only, FGF expressed site in exon 3 of the FGF-4 gene was converted to a BamHI site at the protein level (Miller and Rizzino, 1996a) . These find- constructed by replacing the neomycin resistance gene in the vector Westborough, MA) using a turboblotter (Schleicher and Schuell, Keene, NH) according to manufacturer's instructions. DNA was pSSC (Chauhan and Gottesman, 1992) with the puromycin resistance gene (pPUR, Clontech, Palo Alto, CA) to create pSSC-pur.
UV-crosslinked to the membranes with a Stratagene Stratalinker and the membranes were hybridized using QuikHyb (Stratagene) The next step involved the addition of FGF-4 genomic DNA to pSSC-pur. On the 3 side of the puromycin resistance gene, a 2.7-with a 32 P-labeled BamHI to BglII fragment that is located downstream from the targeting construct. Positive clones were then conkb fragment of the FGF-4 gene was inserted into pSSC-pur between its BamHI and ClaI sites. The 2.7-kb fragment used in this vector firmed by digestion with BsgI and subsequent Southern blot analysis. This analysis identified four FGF-4 0/0 ES cell clones (FD6, GB3, extended from the BglII site in exon 3 to the BamHI site in the 3 flanking region of the gene. On the 5 side of the puromycin resis-HD3, and IC3). DNA from each of the four clones was hybridized with a puromycin probe and only a single copy of the puromycin tance gene cassette, a 4.5-kb fragment from the FGF-4 gene was inserted. The 4.5-kb fragment extended from the XhoI site in the gene was detected (data not shown). 5 flanking region of the FGF-4 gene to the AscI site in intron 1. Thus, the resulting gene-targeting vector contained the puromycin
Generation of FGF-4
//0 Mice resistance gene flanked by two regions of the FGF-4 gene such that the selection marker replaced exon 2 and part of exon 3 of the FGF-FGF-4 //0 ES cells were microinjected into C57BL/6 mouse blas-4 gene.
tocysts to produce chimeric mice, and male chimeras were bred with C57BL/6 females to produce heterozygous offspring as described previously (Mansour et al., 1993) . Heterozygous males and
Electroporation of ES Cells and Drug Selection
females were mated to determine the fate of FGF-4 0/0 offspring. Heterozygous offspring were identified by Southern blot analysis of The conditions for electroporation and drug selection during the tail DNA with the BamHI-SpeI 3 flanking probe described above. first round of gene targeting have been described previously (ManWhere indicated, embryos (8.5 days of gestation) were genotyped sour et Deng and Capecchi, 1992) . To inactivate the secby PCR using yolk sac DNA and three primers based on the seond FGF-4 allele, 342 FGF-4 //0 ES cells (1-3 1 10 7 ) were washed quence of the FGF-4 gene (Brookes et al., 1989) . A primer (5-AGTtwice in PBS, resuspended in PBS (0.8 ml) containing 20 mg of the GCTCCTCCTGAGGGGTAG) from the antisense strand of the targeting vector (linearized with Eco47 III), and electroporated with FGF-4 gene starting at position 1708 (relative to the transcription a Bio-Rad gene pulser (240 V, 500 mF, 0.4 cm cuvette). After electrostart site) and a primer (5-TAGCCAGAGCCAGGCTGGGTT) poration, 342 ES cells were plated on six 100-mm gelatin-coated from the sense strand at position 1193 generate a product of approxtissue culture dishes in medium supplemented with recombinant imately 500 bp from the wild-type allele. The primer from the FGF-4 (10-15 ng/ml) (R&D Systems, Inc., Minneapolis, MN). Puroantisense strand of the FGF-4 gene and a third primer (5-TCTATCmycin (Sigma) was added to the media 18-24 h after electropora-GCCTTCTTGACGAGTTC) from the neomycin resistance gene tion at an initial concentration of 0.1 mg/ml, which was increased cassette generate a product of approximately 300 bp from the allele to 0.2 mg/ml on the third day and 0.5 mg/ml on the fourth day after inactivated by the gene targeting vector described in Fig. 1A . electroporation. During the second day after electroporation, G418 (200 mg/ml, active reagent, Gibco/BRL) and gancyclovir (2 mM, Cytovene, Syntex Laboratories, Palo Alto, CA) were added. The cells
Bioassay for FGF Activity
were refed daily until the majority of the cells died in response to puromycin, G418, and gancyclovir. Thereafter, the cells were refed A [ 3 H]thymidine incorporation bioassay was used to measure the every other day. Twelve days after electroporation, selected coloamount of FGF-4 in media conditioned by ES cells as described nies were trypsinized and reseeded without drugs in 96-well plates previously (Miller and Rizzino, 1996b) . This bioassay employs quion a feeder layer of embryonic fibroblasts. escent NR-6-R1 cells, which are EGF receptorless NIH 3T3 cells that were selected for a strong response to FGFs (Rizzino and Ruff, 1986) . ES-cell-conditioned medium was prepared by replacing the
Screening of Drug-Selected ES Cells by Southern
serum-supplemented culture medium of the cells with serum-free
Blot Analysis
medium (DME/F12 containing 45 mg/ml heparin to stabilize any FGF activity). After 15 h, the serum-free conditioned media were Drug-resistant clones were screened by Southern blot analysis collected, and cell numbers were determined by trypsinizing the to identify ES cell clones in which the FGF-4 gene had been inacticells and counting them electronically with a Coulter counter. The vated. For this purpose, genomic DNA was isolated from cells seconditioned media were concentrated approximately 20-fold using lected during the first round of gene targeting as described preCentriprep 10 columns (Amicon) and stored at 080ЊC until assayed. viously (Condie and Capecchi, 1993) . The DNA was digested with BamHI and probed with a 0.8-kb SpeI-BamHI DNA fragment from the 3 end of the FGF-4 gene, which was not contained in the Northern Blot Analysis targeting vector. Southern blot hybridization was performed using standard protocols (Thomas and Capecchi, 1987 (Miller et al., 1988) . DNA was digested with NsiI (New England Biolabs, Beverly, MA) and separated on an 0.8% agarose gel. Southacetate, and 1 mM EDTA), 2.2 M formaldehyde, and 50% formamide at 65ЊC for 15 min. The samples were subjected to electroern blots were performed using standard protocols. In brief, DNA was transferred to a nylon membrane (Micron Separations, Inc, phoresis in a 1% agarose gel containing 11 Mops running buffer
Isolation and Properties of FGF-4 0/0 ES Cells and 0.22 M formaldehyde and transferred to a MSI nylon membrane into the third exon of the FGF-4 gene (Fig. 1A ). This cassette, (Fisher Scientific, Pittsburgh, PA) in 101 SSPE (1.5 M NaCl, 0.1 M which disrupts the FGF-4 gene, contains a promoterless NaH 2 PO 4 , and 10 mM EDTA, pH 7.4) that was subsequently UVLacZ gene and a neomycin resistance gene under the control crosslinked. The membrane was prehybridized in a solution conof the MCl promoter. R1 ES cells were electroporated with taining 51 SSPE, 51 Denhardt's, 50% formamide, 1% SDS, and the gene-targeting vector and subjected to drug selection in 100 mg/ml denatured salmon testis DNA for 2 h at 42ЊC. Hybridizamedium containing G418 and gancyclovir using methods tions were performed with 32 P-labeled probes in the buffer described described previously (Mansour et al., 1988; Deng and Capec- the drug-resistant ES cell clones were homologous recombiscript size. The b-actin fragment, isolated from the plasmid pHFbAnants (data not shown).
1 (Gunning et al., 1983) , was used to confirm equivalent loading FGF-4 //0 ES cells identified by the above screen were used of samples. The remaining DNA probes were prepared as previously to generate germline chimeric mice by injecting the cells described (Miller and Rizzino, 1996b 
RESULTS
generates a 13-kb NsiI fragment. In contrast, the puromycinbased targeting vector introduces a new NsiI restriction site
Targeted Disruption of the FGF-4 Gene
into the gene resulting in a 5.4-kb NsiI fragment. During the initial screen, four doubly targeted ES cell clones were The immediate goal of the work described in this report is to determine whether FGF-4 produced by ES cells affects identified (FD6, GB3, HD3, and IC3) (Fig. 1C) . Correct targeting was confirmed by digesting the DNA from each of their growth and/or their differentiation. Toward these goals, we sought to create ES cells in which both alleles these clones with BsgI, which produces a 4.9-kb fragment from the wild-type allele and fragments of 6.1 and 6.4 kb of the FGF-4 gene were inactivated sequentially by gene targeting. The first allele was inactivated using a gene tarfrom the first and second targeted alleles, respectively ( 0/0 ES cell clones, As indicated above, recombinant FGF-4 was added to the GB3 and FD6, even when added at a 10-fold higher concenmedium to guard against the possibility that the FGF-4 protration, did not stimulate thymidine incorporation above duced by ES cells is an essential autocrine growth factor.
background. Moreover, no inhibitory activity was detected However, as described in the next section, the growth of in medium conditioned by the FGF-4 0/0 ES cells when it FGF-4 0/0 ES cells is not dependent on the addition of recomwas mixed with medium conditioned by FGF-4 /// ES cells binant FGF-4 to the culture medium. Hence, we were able (Fig. 2) . Taken together, these findings confirm that the to culture the cells in medium that was not supplemented FGF-4 gene has been knocked out, and argue that FGFwith FGF-4. This enabled us to collect medium conditioned 4 0/0 ES cells do not release other FGF-related mitogenic by FGF-4 0/0 ES cells and verify with a bioassay that the growth factors, such as FGF-1 and FGF-2, which are known FGF-4 gene had been inactivated. For this purpose, we emto stimulate thymidine incorporation in the bioassay used ployed a bioassay based on mitogenic stimulation of [ 3 H]-in this study. thymidine incorporation by quiescent NR-6-R1 mouse fiPrevious studies with EC cells and ES cells failed to obbroblasts. These cells are EGF-receptorless NIH 3T3 cells serve any growth stimulation when FGFs, including FGFthat were selected for enhanced response to FGFs (Rizzino 4 , were added to the culture medium (Heath and Rees, 1985; and Ruff, 1986) . This bioassay has been used in several other Rizzino et al., 1988; Miller and Rizzino, 1996b) , even studies to monitor the production of FGF-4 by EC cells and though they express receptors for FGFs ES cells (Rizzino et al., 1988; Miller Mummery et al., 1993) . Although it is possible that they and Rizzino, 1996a,b) . In the current study, conditioned medo not require FGF-4 for growth, it is also possible that they dia were collected from nontargeted ES cells ( (Fig. 2) . As in the case of ate rapidly without the addition of FGF-4 to the culture recombinant FGF-4 and FGF-4 produced by EC cells (Rizmedium. Thus, we examined whether prolonged proliferazino et , heat treatment (70ЊC tion of FGF-4 0/0 ES cells required the addition of recombifor 10 min) of conditioned media from FGF-4 /// ES cells nant FGF-4 to their culture medium. For this purpose, two of the gene inactivated ES cell clones, GB3 and FD6, were cultured on a feeder layer in medium without FGF-4 supplementation for ú20 generations (ú6 passages). During that ú20 generations (ú6 passages), their doubling times were 4 for their survival nor respond to it mitogenically. In this regard, it should be stressed that the serum present in the approximately 17 h with or without FGF-4 (Table 2) . Thus, all of the evidence argues that ES cells neither require FGFmedium used to culture the ES cells was unlikely to contain FGF activity, since the serum was heat-inactivated (56ЊC with distinct cell borders (Fig. 4A) . In direct contrast to the colonies formed by R1 ES cells, the vast majority (ú85%) for 30 min) under conditions known to inactivate FGFs, such as FGF-1, FGF-2, and FGF-4 Ties- of the colonies formed by FD6 FGF-4 0/0 ES cells had few if any associated differentiated cells (Fig. 4B) . Equally imman et al., 1988) . Finally, it is noteworthy that FGF-4 0/0 ES cells cultured in the absence of recombinant FGF-4 exhibit a portant, addition of FGF-4 during the clonal growth of the cells led to dramatic increases in the presence of differentimorphology typical of ES cells whether they were cultured on a growth-inactivated feeder layer (data not shown) or on ated cells in the FD6 ES cell cultures (Fig. 4C) . Interestingly, the morphology of the differentiated cells formed under gelatin-coated surfaces in the absence of a feeder layer (Fig.  3) . Specifically, the ES cells grew as tightly packed colonies, these conditions (Figs. 4A and 4C) is similar to that of parietal extraembryonic endoderm. In this experiment, the cells and have minimal cytoplasm and a large nucleus with one or more nucleoli.
were stained with Coomassie blue prior to photography, which uniformly stained the densely packed core of ES cells. These findings make two important points. First, the survival and/or the proliferation of the differentiated cells at
Differentiation of FGF-4 0/0 ES Cells
low density is severely compromised by inactivation of the FGF-4 gene, which leads us to suggest that FGF-4 produced In view of the fact that FGF-4 is not essential for the by the ES cells acts as a paracrine growth factor to promote growth of ES cells, yet it is essential during early embryonic the growth of the differentiated cells that form spontanedevelopment, we examined the differentiation of FGF-4 0/0 ously at low density. However, the possibility remains that ES cells under two different culture conditions: RA-induced FGF-4 promotes the differentiation of ES cells. Second, condifferentiation and spontaneous differentiation at low cell sistent with our FGF bioassay (Fig. 2) , FGF-4 0/0 ES cells do densities. In both cases, the ES cells were plated in the not appear to produce significant amounts of FGFs that are presence of LIF without a feeder layer. At low cell density, functionally related to FGF-4. ) ES cells, and their differentiated progeny, which formed after a 96-h exposure to RA. Transcripts for Endo B and tPA were upregulated significantly when R1 ES and FD6 ES cells were treated with RA ( Fig. 8 ; compare lanes 1 and 2, or lanes 4 and 5, respectively), indicating that both FGF-4 /// and FGF-4 0/0 cells had undergone differentiation. However, no laminin B1 and only low levels of type IV collagen transcripts were observed in the absence of exogenously added FGF-4. When FGF-4 was added to the culture medium, significant differences were revealed between the populations of differentiated cells derived from FGF-4 /// and FGF-4 0/0 ES cells. Specifically, laminin B1 transcripts were observed and transcripts for type IV collagen were elevated, but only for differentiated FGF-4 0/0 cells (Fig. 8, lane 6) . This enhancement . For this purpose, dium after 2 days and FGF-4 (5 ng/ml) was added daily. Cell numNorthern blot analysis was used to probe for the presence bers were determined daily with a Coulter counter. The values of transcripts for four genes that are expressed by parietal shown represent the mean number of cells in triplicate wells. Stanextraembryonic endoderm: type IV collagen, keratin 18 dard deviations were less than 11% of the mean. This experiment (Endo B), tissue plasminogen activator (tPA), and the B1 was repeated in whole or in part more than six times. The data chain of laminin (Adamson and Ayers, 1979; Singer et al., presented here are derived from an experiment performed in parallel with the experiment shown in Fig. 6. 1986; Marotti et al., 1982; Hogan, 1980) . Poly(A) / RNA was
Isolation and Properties of FGF-4 0/0 ES Cells
pected, since FGF-4 increases the number of differentiated cells, especially in the cultures of the differentiated cells derived from FGF-4 0/0 ES cells (Figs. 5 and 7) . Thus, although differentiation of ES cells appears to be accompanied by an increase in cell death, no differences were observed in the amount of DNA fragmentation exhibited by the FGF-4 /// -and the FGF-4 0/0 -differentiated cells, nor did FGF-4 appear to suppress DNA fragmentation in either population of differentiated cells. Nonetheless, it should be borne in mind that apoptosis does not always culminate in the cleavage of DNA into internucleosomally sized fragments (Ucker et al., 1992) . However, during a 4-day period, the addition of Z-VAD (0.2-20 mM), a general caspase inhibitor, which inhibits apoptosis, did not increase the number of differentiated cells in cultures of FD6 ES cells undergoing differentiation in response to RA (data not shown). Based on these /// counterparts. Previous studies have demonstrated that retinoic acid can induce both differentiation and apoptosis in F9 EC cells (Atencia et al., 1994) . Hence, we sought to determine whether the increased cell death upon differentiation of FGF-4 0/0 ES cells was due to apoptosis. In most instances, cells undergoing apoptosis exhibit cleavage of DNA into internucleosomally sized fragments. Therefore, we employed a DNA laddering assay to Both wild-type and mutant ES cells exhibited approxiindicated, FGF-4 (20 ng/ml) was added to the culture medium when mately the same amount of DNA laddering (Fig. 9) , and no the cells were plated. DNA was isolated 48 h later, radiolabeled, increases were observed 24 h after the addition of RA (data type or FGF-4 0/0 ES cells (Fig. 9 ). This result was not ex- a 61 days after the mice were injected with 10 6 ES cells, the tumors were resected, fixed in 10% buffered Formalin, and processed for histopathological analysis as described under Materials and Methods. However, two of the R1 tumors were removed at 30 and 47 days after injection. In addition, one of the 342 tumors and one of the , and FGF-4 0/0 ES cells to form teratocarcinomas To address whether inactivation of the FGF-4 gene alters (tumors composed of a wide range of differentiated cell the ability of ES cells to form a wide range of differentiated types derived either directly or in multiple steps from ES cell types, the histopathology of the tumors was examined. cells). In this study, two questions were addressed. First, do
We determined that ES cells with one or both alleles inacti-ES cells with one or both inactivated FGF-4 alleles retain vated retained the capacity to differentiate into many differthe potential to form tumors in syngeneic mice? Second, ent cell types, including cells derived from each of the three does inactivation of the FGF-4 gene alter the ability of the embryonic germ layers (Table 3) . Interestingly, one of the cells to undergo differentiation or to form a wide range of tumors derived from GB3 ES cells (FGF-4 0/0 ), like one of the differentiated cell types? For these studies, strain 129/SvJ tumors derived from R1 ES cells and 342 ES cells, exhibited mice were used because R1 ES cells were derived from limited differentiation. However, this GB3 tumor was the mouse strain 129. Each ES cell genotype formed tumors smallest tumor observed in the study. In contrast, another when injected subcutaneously into the hind flank of the tumor derived from this ES cell clone, which was produced mice. In the case of the R1 ES cells, tumors formed in each from higher passage GB3 ES cells, formed the largest tumor of the three mice injected. In the case of the 342 ES cells, in the study and this tumor exhibited a full panel of differentumors formed in 4 of 5 mice injected, and, in the cases of tiated cells types. Thus, it appears that inactivation of the the FD6 and GB3 ES cells, tumors formed in 6 of the 11 FGF-4 gene does not prevent FGF-4 0/0 ES cells from differmice injected (Table 3) . We also observed that the sizes of entiating into many of the cell types that typically form the tumors varied between the different ES cell clones, with during the development of teratocarcinomas. Nonetheless, R1 ES cells and 342 ES cells generally forming larger tumors it is possible that the frequency at which certain differentithan those formed by FD6 and GB3 ES cells. However, the ated cell types form (e.g., cartilage) is influenced by inactivalargest tumor observed in this study was derived from GB3 tion of the FGF-4 gene. This possibility can only be addressed by a much larger study. ES cells. Taken together, these findings demonstrate that (Fig. 7) . Another difference is the higher number of dead cells in the cultures igenic and they can give rise to tumors composed of a wide range of differentiated cells. However, as discussed below, derived from FGF-4 0/0 ES cells, especially 2 days after the addition of RA. These observations suggest that the survival there are significant differences in the properties of the differentiated cells that form in vitro when FGF-4 0/0 ES cells of the RA-induced FGF-4
-differentiated cells is significantly lower, and this reduced cell survival is likely to be are treated with RA or when they are plated at clonal densities. Moreover, our studies, in particular those performed related to the virtual absence of differentiated cells in the stock cultures of FGF-4 0/0 ES cells and the low number of at clonal cell densities, suggest that FGF-4 produced by ES cells can act as a paracrine growth factor for their differentidifferentiated cells in cultures of FGF-4 0/0 ES cells plated at clonal densities (Fig. 4) . ated progeny.
Early studies led to the suggestion that FGF-4 might be Another significant difference between the differentiated cells formed by FGF-4 0/0 ES cells and FGF-4 /// ES cells is an autocrine growth factor for ES cells and EC cells. This argument grew out of the finding that these cells both prothe markers that they express. Although both populations of differentiated cells expressed type IV collagen, Endo B, duce FGF-4 and express several FGF-receptor genes. In addition, the FGF receptors expressed by EC cells have been and tPA, only the FGF-4 0/0 -differentiated cells expressed transcripts for the B1 chain of laminin and only when FGFshown to be functional (Miller et al., 1993) . Nonetheless, addition of various FGFs to the medium of EC and ES cells 4 was added to the media. In addition, the expression of transcripts for type IV collagen was greater in cultures of failed to promote their growth under a variety of conditions, including when FGFs were added to serum-containing me-FGF-4 0/0 -differentiated cells cultured with FGF-4. Although detailed studies will be needed to fully understand this dium, serum-free medium or at low cell densities where it is more difficult for cells to condition their culture medium finding, it appears that there are differences in the cell types present in the populations of differentiated cells derived (Heath and Rees, 1985; Rizzino et al., 1988; Miller and Rizzino, 1996b . The studies described derived from FGF-4 0/0 ES cells and FGF-4 /// ES cells appear to be different. One possibility is that the FGF-4 produced in this report definitively resolve this question for ES cells by demonstrating that FGF-4 0/0 ES cells do not require FGFby FGF-4 /// ES cells influences the process of differentiation, which leads to the formation of different cell types. An 4 to proliferate nor do they respond mitogenically to FGF-4 when it is added to their culture medium during shortequally plausible explanation is that the same differentiated cells form initially in the cultures derived from FGF-4 0/0 term or long-term growth studies. FGF-4 is known to be expressed at several points during ES cells and FGF-4 /// ES cells, but there is selective loss of specific differentiated cell types in the cultures derived from mammalian development (Niswander and Martin, 1992) . In addition to its expression during embryogenesis, where FGF-4 0/0 ES cells. Currently, we cannot distinguish between these alternatives and it is possible that both contrib-FGF-4 is essential, FGF-4 is expressed by several other tissues, including in the developing limb where it is thought ute to the cell types that comprise the population of the differentiated cells 4 days after the addition of RA. to play important roles (Laufer et al., 1994; Haramis et al., 1995; Duprez et al., 1996) . In view of the possible impor-
The full significance of the differences between the population of differentiated cells derived from FGF-4 0/0 ES cells tance of FGF-4 later in development, we examined the ability of FGF-4 0/0 ES cells to form tumors in syngeneic mice. and the population derived from FGF-4 /// ES cells remains to be determined. However, the close relationship between Our studies suggest that the potential for FGF-4 0/0 ES cells to form a wide range of cell types in vivo is similar to that ES cells and the totipotent cells of the ICM at the blastocyst stage leads us to suggest several hypotheses. In this regard, of FGF-4 /// ES cells. In this regard, the same range of tissues was observed in tumors derived from both FGF-4 0/0 ES cells the embryonic lethality observed with FGF-4 0/0 embryos in vivo and the degeneration of FGF-4 0/0 blastocysts cultured and FGF-4 /// ES cells. Nonetheless, as discussed below, important differences were observed between FGF-4 0/0 ES in vitro does not appear to be due to the direct dependence of the totipotent cells of the ICM on FGF-4, since FGF-4 cells and FGF-4 /// ES cells when they were induced to differentiate in vitro. The reason why dramatic differences does not appear to be an autocrine growth factor for ES cells. Instead, our findings suggest that the degeneration of FGFwere observed in vitro but not in vivo is likely to be due to the cell types formed. The cell types that are identified 4 0/0 embryos is due to the absence of FGF-4, which is likely to serve as an essential paracrine growth factor for the surreadily in teratocarcinomas (e.g., muscle, cartilage, and nitz, D. M., and Leder, P. (1994) . Murine FGFR-1 is required for vival and/or proliferation of differentiated cells derived from early postimplantation growth and axial organization. Genes the ICM. This possibility is consistent with the finding that Dev. 8, 3045-3057. FGF-4 added to mouse blastocysts developing in vitro inDeng, C. X., Wynshaw-Boris, A., Zhou, F., Kuo, A., and Leder, P. creases the number of parietal extraembryonic endoderm (1996) . Fibroblast growth factor receptor 3 is a negative regulator cells derived from the ICM . Given of bone growth. Cell 84, 911-921. the complexity of these interactions and the importance of Doetschman, T. C., Eistetter, H., Katz, M., Schmidt, W., and FGF-4 during early mammalian development, we believe Kemler, R. (1985 tion mouse development. Science 267, 246-249. Gunning, P., Ponte, P., Okayama, H., Engel, J., Blau, H., and Kedes, L. (1983) . Isolation and characterization of full-length cDNA
